SAN FRANCISCO—The University of California, San Francisco (UCSF) School of Medicine is at the center of a dispute with the federal government after the U.S. Department of Justice concluded that the institution used racial bias in its admissions process for the 2023, 2024, and 2025 intakes.
According
to the Department of Justice, the school allegedly favored certain Black and
Latino applicants over white and Asian applicants, even when the latter had
better academic performance on indicators such as the Medical College Admission
Test (MCAT) and their college GPA. The department maintained that race
influenced various stages of the process, from the initial application to
interviews and admission.
The
federal analysis indicates that, in certain comparison groups, Black applicants
were 12.6 times more likely to be admitted than white applicants with similar
academic and socioeconomic backgrounds, while for Hispanic applicants, the
likelihood was 4.6 times greater than for comparable white applicants.
The
investigation is based on the 2023 U.S. Supreme Court ruling that prohibited
the use of race as a factor in granting advantages or disadvantages in
university admissions. The Department of Justice believes that the practices
identified at UCSF could violate Title VI of the Civil Rights Act of 1964.
UCSF,
however, disputes the government's findings. The university maintains that
academic performance remains a fundamental element of its decisions and that it
also considers clinical experience, research, community service, leadership,
and other individual factors.
The
Department of Justice requested that UCSF respond by October 2 regarding the
possibility of reaching a voluntary agreement to modify its practices. If
negotiations fail, the department has warned that it could file a lawsuit.
The
case is part of a broader federal government investigation into the use of
racial profiling in medical school admissions. Other California institutions,
including UCLA, UC Davis, and UC San Diego, have also been the subject of
similar investigations or allegations during 2016.